Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma

www.nature.com

Immunotherapy using CAR T cells shows promising long-term outcomes for people with the blood cancer myeloma

www.nature.com

paywallMB to

NatureEnglish · 7 days ago

Nature, Published online: 19 August 2025; doi:10.1038/d41586-025-02592-w

A clinical trial reports data from one of the first groups of people with the blood cancer myeloma to receive a type of immunotherapy called CAR T cells.

From Nature via this RSS feed

You must log in or # to comment.

Chat

Nature

nature

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !nature@ibbit.at

Community locked: only moderators can create posts. You can still comment on posts.

Nature is a weekly international journal publishing the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.

Don’t post archive.is links or full text of articles, you will receive a temp ban.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

1 user / day
2 users / week
9 users / month
15 users / 6 months
1 local subscriber
8 subscribers
522 Posts
4 Comments
Modlog